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Summary 
Background: In the UK, although 40% of patients with lung cancer are diagnosed 
following an emergency admission (EA), data is limited on their needs and 
experiences as they progress through diagnostic and treatment pathways. 
Methods: Prospective data collection using medical records, questionnaires and in-
depth interviews. Multivariate logistic regression explored associations between 
diagnosis following EA and aspects of interest. Questionnaire responses with 95% 
confidence intervals were compared with local and national datasets. A grounded 
theory approach identified patient and carer themes. 
Results: Of 401 patients, 154 (38%) were diagnosed following EA; 37 patients and 
six carers completed questionnaires and 13 patients and 10 carers were interviewed. 
Compared to those diagnosed electively, EA patients adjusted results found no 
difference in treatment recommendation, treatment intent or place of death. Time to 
diagnosis, review, or treatment was 7–14 days quicker but fewer EA patients had a 
lung cancer nurse present at diagnosis (37% vs. 62%). Palliative care needs were 
high (median [IQR] 21 [13–25] distressing or bothersome symptoms/issues) and 
various information and support needs unmet. Interviews highlighted in particular, 
perceived delays in obtaining investigations/specialist referral and factors influencing 
success or failure of the cough campaign. 
Conclusions: Presentation as an EA does not appear to confer any inherent 
disadvantage regarding progress through lung cancer diagnostic and treatment 
pathways. However, given the frequent combination of advanced disease, poor 
performance status and prognosis, together with the high level of need and reported 
short-fall in care, we suggest that a specialist palliative care assessment is routinely 
offered. 
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Introduction 
In the UK, survival after a diagnosis of lung cancer appears lower compared to 
countries with similar healthcare systems.1 In part, this is explained by differences in 
stage at presentation, with proportionally fewer diagnosed with early stage disease.1 
Diagnostic delay is also suggested by the fact that about 40% of patients with lung 
cancer in the UK are diagnosed after an emergency admission to hospital.2 Analysis 
of a large dataset of patients with non-small cell lung cancer found, compared to 
patients diagnosed electively, that the most strongly associated clinical features in 
those diagnosed after an emergency admission were stage IV disease and a poor 
performance status (Eastern Cooperative Oncology Group 4), which contributed to a 
poorer prognosis (median survival 77 vs. 260 days, 1-year survival 17% vs. 41%).3 
Despite diagnosis after emergency admission being common and having such a poor 
outlook, there has been relatively little research focusing specifically on the needs of 
this group and their experiences as they go through the diagnostic and treatment 
pathways; they are unlikely to be captured by the National Cancer Patient 
Experience Survey which is biased toward fitter patients.4 
 This study used a mixed-methods approach to explore in detail the 
characteristics, outcomes, needs and experiences of a cohort of patients diagnosed 
with lung cancer following an emergency admission. The aim was to identify areas 
where there may be potential to improve the care provided so as to inform the need 
for further focused research. During part of the recruitment period, the English 
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Department of Health ran a lung cancer awareness ‘cough campaign’, which 
permitted capture of patient and carer views relating specifically to this. 
 
Methods 
Setting, participants and data collection 
This was a prospective survey between 1st December 2012 and 31st November 
2013 at Nottingham University Hospitals NHS Trust. All patients assigned a 
diagnosis of lung cancer at the lung cancer multidisciplinary team meeting (MDT) 
were identified and categorised as either diagnosed following an emergency 
admission or electively. Basic demographic and other data recorded included 
aspects defined as follows; socioeconomic status (Index of Multiple Deprivation 
Score based on postcode, separated into quintiles), investigations undertaken in 
secondary care (following emergency admission or the receipt of a referral letter from 
the general practitioner, until the date of the treatment recommendation of the lung 
cancer MDT), time taken to diagnosis (the number of days from the date of 
emergency admission or from receipt of a referral letter from the general practitioner, 
to either a histocytology report or assignment of a clinical diagnosis by the lung 
cancer MDT), cancer stage (International Association for the Study of Lung Cancer, 
TNM staging classifications, 7th edition) and best supportive care (a treatment 
recommendation of the lung cancer MDT when specific anticancer treatment is either 
inappropriate, e.g. due to a poor performance status, or not currently indicated, e.g. 
palliative radiotherapy). 
 All patients diagnosed with lung cancer following an emergency admission 
were potentially eligible to complete the questionnaires: Eastern Co-operative 
Oncology Group (ECOG) performance status, Charlson co-morbidities index,5 
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Sheffield Profile for Assessment and Referral to Care (SPARC©) holistic needs 
questionnaire6–8 and the 2012 National Cancer Patient Experiences Survey.9 The 
latter was modified by removing irrelevant questions and those relating to information 
already collected. If the patient was unable to participate, an adult informal carer was 
approached to act as a proxy. Exclusion criteria were the presence of severe 
distress, a lack of capacity to consent, a lack of awareness of the diagnosis of lung 
cancer or an inability to communicate in English. 
 Following completion of the questionnaires, patients and their carers were 
invited to take part in more in-depth interviews, undertaken as detailed in Appendix 
1S. 
 Written informed consent was obtained for the questionnaire and interview 
elements of the study; it was not required for collection of quasi-anonymised data, 
similar to that gathered for the National Lung Cancer Audit. The National Research 
Ethics Service Committee East Midlands – Nottingham 1 (12/EM/0305) approved the 
study and it was adopted onto the UK NIHR portfolio (12993). 
Data handling and analysis 
After an initial descriptive analysis, gender, age, deprivation, performance status, 
diagnosis and stage were assessed by univariate analysis to determine whether 
there were any differences in presenting characteristics for those diagnosed following 
emergency admission or electively. A multivariate model was then fitted including all 
of these variables. We investigated whether a diagnosis following emergency 
admission resulted in a difference in investigations undertaken, treatment 
recommendation, treatment intent and place of death, with these multivariate models 
adjusted for gender, age, performance status, diagnosis and stage. Survival was 
assessed using survival rate, Kaplan-Meier method and a Cox proportional hazards 
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model, adjusted for gender, age, performance status, diagnosis and stage. The start 
date was the date of diagnosis and the end date was the date of death or 1st March 
2014, with all survivors confirmed alive on this date. Mann-Whitney U and Pearson 
Chi-squared tests were used to compare time taken to reach key points in the 
diagnostic pathway, presence of a lung cancer clinical nurse specialist and receipt of 
an active oncological treatment. 
 Proportions with 95% confidence intervals (CI) were calculated for responses 
to the SPARC© questionnaire and compared to a historical dataset of patients 
diagnosed electively generated locally at the time of assessment for a rehabilitation 
service, generally within 4 weeks of diagnosis. Similarly, responses from the modified 
National Cancer Patient Experiences Survey were compared with those obtained in 
the National Cancer Patient Experiences Survey 2012–13 both nationally and locally, 
noting instances where the 95% CI did not encompass the latter. The National 
Cancer Patient Experiences Survey 2012–13 responses are in the public domain 
(www.quality-health.co.uk); they were obtained from patients who had received 
inpatient or day case treatment between 1st September 2012 and 30th November 
2012 and are not limited to those with a recent diagnosis. 
 For the in-depth interviews, a grounded theory10 approach was used to identify 
themes likely to be typical for patients diagnosed following emergency admission and 
their carers. Interviews were recorded, transcribed and entered into a qualitative data 
management package. Coding and thematic analysis were undertaken by two 
researchers (GC, JS) to check validity. Interviews continued until data saturation was 
achieved. Standard procedures for evaluating rigour in qualitative research were 
employed.11 
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 All calculations were performed using Statistical Package for the Social 
Sciences version 20. 
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Results 
Over one year, 401 patients received a diagnosis of lung cancer, of which 154 (38%) 
were following emergency admission (see Fig.1). Emergency admissions were 
mostly via the accident and emergency department (63%); those via the GP were 
either direct (24%), or via an urgent outpatient referral (6%). The remaining 7% were 
emergency transfers from another hospital, care home or nursing home. Emergency 
admissions utilized 1,856 hospital bed days, a median [IQR] of 9 [3–16] per patient. 
Seventeen (11%) patients died during the emergency admission, with 122 (79%) 
discharged home, 10 (6%) transferred to a hospice and 5 (3%) to a 
residential/nursing home or other hospital (see Figs. 1 and 2). 
Demographics 
Patients diagnosed following emergency admission or electively were similar with 
regard to gender (60% vs. 56% male), age (72 (11) vs. 72 (9) years), ethnicity (96% 
vs. 97% white British) and deprivation (Table 1S). However, the group diagnosed 
following emergency admission had a greater proportion of patients with a poor 
performance status (30% vs. 13% ECOG 3–4), a clinical diagnosis (25% vs. 9%) and 
more advanced stage disease (81% vs. 51% stage IIIB/IV). In the univariate model 
and after mutual adjustment in multivariate analysis, ECOG 4, a clinical diagnosis 
and stage IV were strongly associated with diagnosis following emergency admission 
(Table 1S). 
Diagnosis, treatment, survival and place of death 
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Investigations undertaken in secondary care: The adjusted multivariate model found 
that patients diagnosed following an emergency admission were more likely to have 
had a chest x-ray (adjusted OR 6.95, 95% CI 4.01–12.09) or a MRI (adjusted OR 
3.20, 95% CI 1.40–7.29) and less likely to have PET CT (adjusted OR 0.29, 95% CI 
0.12–0.73) as compared to an elective admission (Table 1). 
Time to diagnosis: In those diagnosed following emergency admission the median 
time to either diagnosis or discussion at the lung cancer MDT was 14 days less at 9 
vs. 23 days and 11 vs. 25 days respectively (p<0.001 for both). Fewer patients 
diagnosed following emergency admission had a lung cancer clinical nurse specialist 
present at the time of diagnosis (37% vs. 62%, p<0.001) (Table 1). 
Treatment recommendation: Compared to those diagnosed electively, the proportion 
of patients diagnosed following emergency admission recommended by the lung 
cancer MDT for surgery was lower (5% vs. 22%) and for best supportive care higher 
(50% vs. 19%); consequently, for a higher proportion the treatment intent was 
palliative (95% vs. 72%), with a smaller proportion receiving an ‘active’ oncological 
intervention (46% vs. 79%, p<0.001) (Table 2). After adjusting for confounders, there 
were no significant differences in treatment recommendations between the two 
groups (Table 1). 
Time taken to treatment commencement: Those diagnosed following an emergency 
admission were treated more quickly, with the median time from lung cancer MDT 
treatment recommendation to commencement of an ‘active’ oncological treatment 
seven days less (6 vs. 13 days, p<0.001), as compared to those diagnosed electively 
(Table 1). 
Survival and place of death: Median duration of follow-up was the same for patients 
diagnosed electively and after emergency admission (233 vs. 232 days). Three and 
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12-month survival rates were lower for patients diagnosed following emergency 
admission at 47% vs. 85% and 17% vs. 40% respectively (p<0.001 for both), as was 
median [IQR] survival (67 [33–100] vs. 405 [208–523] days, p<0.001; Table 1, Fig. 
1S). The hazard ratio for death, adjusted for gender, age, performance status, 
diagnosis and stage, was also higher in patients diagnosed following emergency 
admission compared to those diagnosed electively (HR 1.68, 95% CI 1.23–2.28, 
p=0.001). 
 Place of death was similar for patients diagnosed electively or following 
emergency admission, with about 40% dying either in hospital or home, with the 
remainder in a hospice/palliative care unit (16–19%) or a nursing/residential home 
(2–3%); univariate and multivariate analyses revealed no significant differences 
(Table 1). 
Holistic needs assessment and patient experience 
Forty-three participants (37 patients and 6 carer proxies) completed the 
questionnaires, representing 28% of patients diagnosed following emergency 
admission (for study flow, see Fig. 2S). Participants and non-participants were similar 
with regard to mean age (71 vs. 72 years), sex (63 vs. 60% male), metastatic (stage 
IV) cancer (74 vs. 66%) and median [IQR] ECOG performance status (1 [1–3] vs. 2 
[1–3]). Participants Charlson co-morbidities index score was 9 [8–12] with common 
comorbidities COPD (23%), diabetes mellitus (16%) and prior myocardial infarction 
(12%). 
 Patients reported a median [IQR] overall total of 21 [13–25] symptoms or 
issues causing distress or bother, the most common being ‘feeling tired’, ‘feeling 
sleepy in the day’, ‘feeling weak’ and ‘worrying about the effect your illness is having 
on other people’ (Table 2; for full responses see Table 2S). By comparison, in the 
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larger historical dataset, patients diagnosed electively reported a lower median [IQR] 
overall total of 15 [10–21] symptoms or issues. Although the order varied, seven out 
of the top 10 symptoms or issues were the same. There were higher proportions of 
patients diagnosed following emergency admission reporting ‘feeling sleepy during 
the day’, ‘feeling weak’, ‘feeling everything is an effort’ and ‘worrying about the effect 
your illness was having on other people’. 
 Most responses to the modified National Cancer Patient Experiences Survey 
were similar to those obtained nationally and locally in the 2012–13 National Cancer 
Patient Experiences Survey (for full responses see Table 3S). However, for several 
questions, the responses from patients diagnosed following emergency admission 
were suggestive of a potential shortfall in care, with the 95% CI falling outside of the 
national and/or local Nottingham University Hospitals results (Table 3). Compared to 
the local results, patients diagnosed following emergency admission appeared to be 
more likely to have seen their GP five or more times (13, 30%) and to highlight an 
apparent lack of sufficient information and a desire for more information in relation to 
diagnostic tests and about the type of cancer they had (Tables 3 and 3S). 
Conversely, in the overall NHS care summary question, more patients diagnosed 
following emergency admission reported that they had received ‘too much’ 
information about their condition and treatment (Table 3); however, the gap between 
the 95% CI and the national response was small, i.e. 12% [2–22] vs. 1%. Fewer were 
given the name of a Lung Cancer Nurse Specialist (Table 4), although a higher 
proportion contacting the Lung Cancer Nurse Specialist found it easy to do so (Table 
3S). Regarding inpatient care, more thought there were insufficient nurses on duty. 
On leaving hospital, fewer reported being given written information about what to do 
and not do and who to contact if worried after discharge. This extended to lower 
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levels of information provided by doctors and nurses as required by family/informal 
carers to help care for those diagnosed following emergency admission at home. 
Fewer patients diagnosed following emergency admission felt they received enough 
care from health and social care services (Tables 3 and 3S) 
Themes arising from qualitative interviews 
Interviews were conducted with 13 patients (7 female) and 10 carers, reflecting on 
the experiences of 20 patients. The interviews included three interview dyads (two 
wives with their husbands, one daughter and her mother), four carers alone (three 
daughters and one daughter-in-law) and three bereaved carers (two widows and one 
stepson). The mean (range) age of patients was 71 (48–91) years. Similar issues 
emerged across the interviews, suggesting data saturation was achieved. Six themes 
were identified summarized below. For a detailed overview, with additional illustrative 
comments, see Appendix 2S. 
Experiences prior to hospital admission 
Not all had seen their GP prior to admission. For those who had, some considered 
they had received prompt and effective care. Others felt it had taken too long to 
obtain tests or referral to secondary care, with several seeing their GP multiple times 
before a referral was made. Some felt this was due to the GP attributing their 
symptoms to another cause: 
Oh, I went to the doctor’s but she told me I was depressed so I went in the walk-in 
centre… they did a blood test which showed that there was white cells in my 
blood, and in my water. And there was also blood in my water. So…she phoned 
the doctor’s and made an appointment, so I went back to the doctor’s and then 
she took another blood test and then we waited and then it came back as low 
sodium, and that’s how I was admitted to hospital (49 year old female). 
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Delay in seeking help 
Generally, patients were aware that they should go to their GP if they had a cough for 
three or more weeks, either because of the cough campaign, knowing someone with 
lung cancer, or ‘common sense’, and four of seven patients with a cough did so. The 
three that did not attributed the cough to another cause (e.g. smoking, a drug side 
effect) or did not ‘believe’ the cough campaign adverts. Those without a cough also 
reported attributing their symptoms to other causes (e.g. tiredness because of ‘old 
age’) or a pre-existing condition (e.g. increasing breathlessness due to asthma). 
Cough campaign awareness 
Awareness of the cough campaign was not universal, but it had directly led some to 
see their GP, with carers using the campaign message to encourage this. However, 
others considered the adverts unhelpful, choosing to ignore the message or because 
carer encouragement had the unintended opposite effect: 
And it don’t matter how many adverts you put on telly…they don’t work. You know 
that one where they had where the cigarette was burning, it showed you all these 
mutating cells…Laugh, just laugh at it. Nobody takes the blindest bit of notice (61 
year old female patient with cough). 
And you see, also, there were a lot of adverts on the telly round about that time as 
well about coughing. And I used to make snide remarks to him, [laughter] about it. 
(female carer of 69 year old male patient who had a cough) Which has the reverse 
effect on me, because, yeah, my back goes up, you see (69 year old male patient 
with cough). 
Experiences of inpatient care 
Although descriptions of hospital care were mostly positive, most identified areas for 
improvement. These included general issues such as increasing staffing levels and 
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improving the quality of the food, to more specific suggestions to automatically obtain 
support from Macmillan Cancer Support at diagnosis. 
Receiving the diagnosis 
This was a significant event for patients and carers and experiences varied. Some 
reported a poor experience in how the news was relayed (e.g. bluntly, lack of privacy) 
with others feeling that the professional handled the encounter well. Some wanted to 
know about prognosis, but noted that the topic did not arise as part of the diagnosis 
interview. Information requirements varied between some patients and their carers, 
e.g. regarding prognosis, what to expect in the future. 
Experiences of outpatient/community care 
Some patients reported outpatient treatment such as chemotherapy as a positive 
experience, in part because of the regular follow-up and that something was ‘being 
done’. Others were critical of some aspects, e.g. long waits and treatment times 
involved. Family and friends were a common source of support for patients but there 
was variation in professional support; some felt well supported, e.g. by their general 
practitioner, Macmillan nurse, lung cancer nurse specialist or research nurse, but 
others less so, e.g. because of no contact from the general practitioner, or a lack of 
practical help: 
And [laughs] my God, there was so much help to die and no help to live, is what 
we found. But all the help to die wasn’t practical help. A great deal of it was all 
about, to my mum, How are you? How are you? And my mum doesn’t want that 
(female carer of 78 year old male patient). 
 
Discussion 
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The main novel findings of this study are that a diagnosis of lung cancer following an 
emergency admission per se does not appear to influence treatment 
recommendation, treatment intent or place of death. This suggests that this mode of 
presentation does not specifically disadvantage patients in how they progress 
through the diagnostic and treatment pathways. On the contrary, the time taken to 
diagnosis, discussion at the lung cancer MDT and commencement of an ‘active’ 
oncological treatment was a median of 1–2 weeks quicker than those diagnosed 
electively. This most likely reflects the additional time taken for elective referrals to be 
seen in secondary care, along with those diagnosed following an emergency 
admission being more likely to present with situations that require urgent treatment, 
e.g. radiotherapy for spinal cord compression. 
 Like others, we have found that patients diagnosed following an emergency 
admission are more likely to have a poor performance status (ECOG 4), a clinical 
diagnosis, advanced disease (stage IV) and a reduced survival.2,3 These features are 
likely to mostly explain the differences found between patients diagnosed following 
an emergency admission or electively in relation to the proportions receiving specific 
treatment recommendations (e.g. best supportive care 50% vs. 19%) and treatment 
intent (palliative in 95% vs. 72%) and, in part, the differences seen in some 
investigations undertaken in secondary care, i.e. those diagnosed following 
emergency admission were more likely to have had a chest x-ray and MRI, and less 
likely to have had a PET CT. The most likely explanations are that patients admitted 
as an emergency often present with symptoms which warrant a chest x-ray, e.g. 
increasing breathlessness; conversely, those diagnosed electively are likely to have 
had a chest x-ray undertaken in primary care. MRI is mostly undertaken for 
suspected spinal cord compression, which generally presents as an emergency. 
 15 
Finally, PET CT is mostly undertaken in patients with early stage disease potentially 
suitable for curative treatment. 
 The SPARC© holistic assessment questionnaire revealed that patients 
diagnosed following emergency admission had a median of 21 wide-ranging 
symptoms or issues, with 8 causing ‘very much’ or ‘quite a bit’ of distress or bother. 
This compares to 15 and 5 respectively, in our local SPARC© dataset of patients with 
lung cancer diagnosed electively (n=538, unpublished data). Although seven of the 
10 most common issues were similar, ‘feeling sleepy during the day’, ‘feeling weak’, 
‘feeling everything is an effort’ and ‘worrying about the effect your illness was having 
on other people’ appeared more common in patients diagnosed following emergency 
admission, which may reflect a more advanced disease stage and more ‘urgent’ 
nature of the situation. Use of different scales limits direct comparison with previous 
work, but our findings are in keeping with the high symptom burden of lung cancer 
reported by others.12 
 The modified National Cancer Patient Experiences Survey suggests that 
patients diagnosed following emergency admission are more likely to have visited the 
GP five or more times prior to diagnosis. Multiple visits to the GP before diagnosis 
have been well described,13 with the frequency 4–12 months preceding diagnosis 
independently predictive of a diagnosis of lung cancer.14 Patients diagnosed following 
emergency admission also appear less likely to have their information and support 
needs met. Some of these issues may be specific to Nottingham University 
Hospitals. A notable difference was that compared to those diagnosed electively, 
fewer patients diagnosed following emergency admission had a lung cancer nurse 
specialist present specifically at the time of diagnosis, as recommend by national and 
specialty guidelines.15,16 This probably reflects the fact that the lung cancer nurses 
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are based on a different hospital site to the one which deals with emergency 
admissions. Nonetheless, this discrepancy should be explored further in other 
centres. Others issues are probably more generic, varying between simple to correct, 
e.g. providing written information to patients regarding investigations undertaken as 
an inpatient, as sent routinely with appointments for outpatient investigations, or 
forming part of a longer term strategy, e.g. improved communication skills training. 
 The qualitative interviews identified several themes similar to those previously 
identified as important to patients with lung cancer and their carers.17,18 Although 
most were satisfied with the care they received, some specific criticisms, e.g. time 
taken for tests or referral to secondary care, have also been noted by others.17 
Although some patients saw their GP as a direct consequence of the cough 
campaign, others chose to ignore its message or attributed their cough to other 
causes; such misattribution of cough or other symptoms is a recognised factor in 
delayed diagnosis.19–22 Our data highlights the challenges the cough campaign faces 
in trying to change both knowledge and behaviour, and also the limitations of 
focusing on one symptom. Although, cough is quoted as the most common 
presenting symptom,23 in this study, and in our larger local dataset (n=538), based on 
causing any degree of distress or bother, cough was ranked 7th and 3rd. 
Deficiencies in health and social care support in the community is also a previously 
identified theme.17 
 There is limited previous work which has exclusively studied patients 
diagnosed with lung cancer following emergency admission and a particular strength 
of this study is the overall depth of detail it provides. Our cohort is likely to be 
reflective of those presenting to other centres in the UK, with the proportion 
diagnosed following an emergency admission (38%) and the association with 
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advanced disease, poor performance status and reduced survival typical of that 
reported in larger UK data sets.2,3 
 The main limitations of this study are being a single centre with a relatively 
small sample size and scope for self-selection bias. This probably explains why, 
unlike others, we found no association between diagnosis following emergency 
admission and deprivation, gender or age.3,24,25 Nonetheless, we calculated the 
precision to which we could estimate descriptive data values at a population level (6–
8%; Appendix 1S). Further, participants completing questionnaires appeared 
representative of the overall group. It is possible that there were some patients with 
lung cancer who were not referred to the lung cancer MDT. However, this is unlikely 
to represent a significant number; a local ‘rad alert’ system is in operation which 
sends a copy of any chest x-ray report suspicious of lung cancer to the lung cancer 
MDT and previous comparisons with local cancer registry data indicate that the lung 
cancer MDT captures all but a few patients with lung cancer (Professor David 
Baldwin, personal communication). We did not record investigations undertaken in 
primary care, which would have aided more definite interpretation of our data relating 
to chest x-rays, nor if the patient saw the lung cancer nurse specialist subsequent to 
the time of diagnosis, which was the specific focus of our interest, or the specialist 
palliative care team, although referrals are made ad hoc rather than routinely. Having 
anticipated the potential difficulties of recruiting this group to the questionnaire 
element, we, like others, included the provision for informal carers to act as proxies.26 
Carers appear able to reliably report on patients’ observable symptoms and 
experiences of care delivery, although possibly less so for more subjective aspects of 
patients’ experiences, like pain and anxiety.27 The qualitative interviews involved 
numbers of participants typical of previous work.18,19 Participants were a balanced 
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mix of patients and carers, gender and ages, and data achieved saturation. Similar 
themes emerged as reported by others,17,19 suggesting a degree of generalizability, 
but this requires appropriate caution. Interviews were undertaken once, relatively 
soon after diagnosis, aiding recall of events, but themes are known to vary over 
time.17  
Conclusions 
Presentation as an emergency admission does not appear to confer any inherent 
disadvantage regarding progress through lung cancer diagnostic and treatment 
pathways in a busy cancer centre. However, this group often has a poor performance 
status and advanced disease which often results in treatment limited to best 
supportive care and a poor prognosis. In this regard, the themes from the interviews 
highlighting delay in referral to secondary care and factors influencing the success or 
failure of the cough campaign, are particularly relevant. Fewer have a lung cancer 
nurse specialist present at the time of diagnosis which is of potential concern given 
that there are high levels of supportive and palliative care needs and a reported 
short-fall in care. Further research is required to explore how these are best met; in 
the meantime, we suggest that all patients diagnosed following emergency admission 
should be routinely offered a specialist palliative care assessment. 
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Table 1 Data relating to diagnostic and treatment pathways and survival along with odds ratios for diagnosis after emergency admission 
compared with elective diagnosis for selected outcomes. Number (%) unless specified otherwise. 
 
 Diagnosed 
following 
emergency 
admission 
(n = 154) 
Elective diagnosis 
(n = 247) Univariate Multivariate
e 
 
 
 
OR OR [95% CI] 
P value 
Investigations undertakena      
Chest x-ray 95 (62) 65 (26) 4.51 6.95 [4.01–12.09] <0.001 
CT 145 (94) 219 (89) 2.06 2.60 [0.98–6.93] 0.055 
Biopsy (radiologically guided) 35 (23) 94 (38) 0.48 0.77 [0.45–1.33] 0.345 
Biopsy (other) 28 (18) 45 (18) 1.00 0.86 [0.47–1.58] 0.635 
Bronchoscopy 50 (33) 79 (32) 1.02 1.57 [0.94–2.63] 0.087 
MRI 25 (16) 12 (5) 3.80 3.20 [1.40–7.29] 0.006 
PET CT 7 (5) 71 (29) 0.12 0.29 [0.12–0.73] 0.009 
Ultrasound 11 (7) 7 (3) 2.64 2.03 [0.67–6.13] 0.212 
Median [IQR] days from referral/EA to diagnosis 9 [6–16] 23 [15–35]   <0.001 
Lung cancer CNS present at diagnosis 57 (37) 152 (62)   <0.001 
Median [IQR] days from referral/EA to LC-MDTb 11 [8–16] 25 [16–35]   <0.001 
Treatment recommendation of lung cancer MDTb      
Surgery 8 (5) 54 (22) 1 1 0.208 
Chemotherapy + radiotherapy 7 (5) 16 (6) 2.95 0.93 [0.25–3.49]  
Chemotherapy 35 (23) 72 (29) 3.28 1.13 [0.42–3.06]  
Radiotherapy 23 (15) 54 (22) 2.88 1.47 [0.53–4.09]  
Best supportive care only 75 (50) 46 (19) 11.01 2.56 [0.92–7.13]  
Active monitoring 2 (1) 5 (2) 2.70 1.02 [0.13–7.82]  
      
Treatment intent      
Curative 7 (5) 69 (28) 1 1 0.430 
 25 
Palliative 143 (95) 178 (72) 7.92 1.55 [0.52–4.59]  
Received oncological treatmentc 65 (46) 187 (79)    
Median [IQR] days from lung cancer MDT 
recommendation to start of treatmentc 
6 [2–14] 13 [6–25]   <0.001 
Survival      
At 3-months 72 (47) 209 (85)   <0.001 
At 12-monthsd 9 (17) 23 (40)   <0.001 
Median [IQR] days 67 [33–100] 405 [208–523]   <0.001 
Place of death      
Home 44 (40) 39 (40) 1 1 0.787 
Hospital 46 (41) 38 (39) 1.07 0.85 [0.41–1.74]  
Hospice/Palliative care unit 18 (16) 19 (19) 0.84 0.64 [0.25–1.67]  
Nursing/ Residential home 3 (3) 2 (2) 1.33 0.49 [0.04–6.06]  
a. excludes three from total who had no investigations 
b. four patients diagnosed following emergency admission died before the lung cancer MDT 
c. excludes best supportive care and active monitoring, also 17 patients who declined treatment (two diagnosed electively), or died 
before treatment could commence (eight diagnosed following emergency admission, seven diagnosed electively) 
d. based on 58 and 54 patients diagnosed following emergency admission and electively respectively followed up for a minimum of 12 
months 
e. adjusted for gender, age, performance status, diagnosis and stage. 
 
CNS = clinical nurse specialist; CT = computerised tomography; MDT = multidisciplinary team; MRI = magnetic resonance imaging; 
PET = positron emission tomography 
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Table 2 Most frequent symptoms or issues identified by the SPARC© questionnaire 
causing any degree of distress or bother for patients diagnosed following emergency 
admission compared to a historical dataset of patients diagnosed electively; * indicates 
items where the 95% CI fail to overlap 
 
Symptom or issue Patients diagnosed 
following EA 
(n=43) 
Patients diagnosed 
electively (historical 
dataset, n=538) 
 Percentage [95% CI] Percentage [95% CI] 
and rank 
Feeling tired 91 [82–100] 79 [76–82], 1 
Feeling sleepy during the day* 86 [75–96] 68 [64–72], 4 
Feeling weak* 84 [73–95] 55 [51–59], 11 
Worrying about the effect your 
illness is having on other people* 
84 [73–95] 65 [61–69], 6 
Shortness of breath 74 [61–87] 78 [75–82], 2 
Feeling everything is an effort* 74 [61–87] 54 [50–58], 12 
Cough 72 [58–85] 66 [62–70], 3 
Loss of appetite 70 [56–84] 59 [55–63], 9 
Changes in your weight 70 [56–84] 73 [69–77], 5 
Dry mouth 67 [53–81] 52 [48–56], 14 
EA = emergency admission 
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Table 3 Questions in the modified National Cancer Patient Experience Survey where the 95% CI of one or more of the responses from 
patients diagnosed following emergency admission did not encompass the local and/or national 2012–13 results (indicated by *) 
suggesting a shortfall in care. For full results see on-line Appendix B. 
Question Response Diagnosed following EA 
(n=43) 
Lung (NUH)a 
(n=145) 
Lung (national) 
(n=5,018) 
  % (n) 95% CI % % 
Seeing your GP      
How many times did you see your GP (family doctor) 
about the health problem that ultimately led to your 
urgent admission to hospital? 
I saw my GP 5 or more times 30 (13) [16–44]  11* 
Diagnostic tests      
Beforehand, did a member of staff explain the purpose 
of the test(s)? 
Yes, completely 62 (23) [46–78] 90* 84* 
Beforehand, did a member of staff explain what would 
be done during the test procedure(s)? 
Yes completely 69 (27) [54–84] 92* 88* 
Beforehand, were you given written information about 
your test(s)? 
Yes, and it was easy to understand 44 (11) [25–63] 94* 87* 
Finding out what was wrong with you      
When you were told you had cancer, were you given 
written information about the type of cancer you had? 
Yes, and it was easy to understand 44 (16) [28–60] 68* 65* 
Clinical nurse specialist      
Were you given the name of a Lung Clinical Nurse 
Specialist who would be in charge of your care? 
Yes 66 (25) [51–81] 85* 91* 
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Ward nurses      
In your opinion, are there enough nurses on duty to 
care for you in hospital? 
There were always or nearly always 
enough on duty 
48 (20) [33–63] 71* 63 
Information given to you before you left hospital      
Were you given clear written information about what 
you should or should not do after leaving hospital? 
Yes 43 (10) [25–61] 77* 81* 
Did hospital staff tell you who to contact if you were 
worried about your condition or treatment after you 
left hospital? 
Yes 62 (16)  [44–80] 88* 91* 
Did the doctors or nurses give your family or someone 
close to you all the information they needed to help 
care for you at home? 
Yes, definitely 31 (8) [13–49] 60* 61* 
Arranging home support      
After leaving hospital, were you given enough care 
and help from health or social services (For example, 
district nurses, home helps or physiotherapists)? 
Yes, definitely 31 (5) [8–54] 51 57* 
Your overall NHS care      
How much information were you given about your 
condition and treatment? 
The right amount 69 (29) [55–83] 93* 88* 
Too much 12 (5) [2–22]  1* 
a.  only responses to ‘key’ questions are available at an individual trust level.  
CI = confidence interval; EA = emergency admission; NUH = Nottingham University Hospitals NHS Trust 
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